EGFR and breast carcinoma: To evaluate the potential of EGFR and EGFR ligands as predictive biomarkers in relation to earlier detection of metastatic recurrence of breast cancer, we conducted plots depicting the changes in serum levels of each biomarker before systemic recurrence of breast cancer.